骨质疏松治疗决策辅助工具的质量与效果:系统综述与环境扫描
该系统综述与环境扫描旨在识别现有骨质疏松治疗决策辅助工具(DAs),评估其质量与效果,并由患者咨询组提供反馈。研究纳入6项研究(高或不明确偏倚风险)和11个DAs,发现DAs可减少决策冲突、增加共享决策(SDM)和患者骨折风险感知准确性,但无DA完全满足IPDAS认证标准,患者偏好个体化 encounter DAs。
要点
- 骨质疏松DAs可减少决策冲突、增加SDM和骨折风险感知准确性。
- 11个DAs均未完全满足IPDAS减少偏倚的认证标准。
- 患者偏好根据自身需求和风险个体化的 encounter DAs。
核心结论
- 使用决策辅助工具可提高风险感知准确性和共享决策,但工具本身未全面满足国际质量标准和患者需求,需要开发新的决策辅助工具。
研究设计与样本
- 系统综述检索2000至2019年多个文献数据库,并于2019年2月进行环境扫描(2020年3月重复),由两名评审员独立筛选研究、提取数据、评估偏倚风险并使用IPDAS评估DA质量。
- 患者咨询组(有骨质疏松和脆性骨折经历的患者及照护者)参与讨论组,审查DA样本并表达偏好。
主要发现
- 共识别6项研究,偏倚风险为高或不明确。
- 使用骨质疏松DA相比基线减少决策冲突,增加SDM,相比对照组提高患者感知骨折风险的准确性。
- 共识别11个DAs,均未完全满足IPDAS认证的全部标准(减少偏倚)。
- 公共贡献者偏好根据患者自身需求和风险个体化的 encounter DAs。
临床怎么用
- 骨质疏松DA可减少决策冲突、增加SDM和骨折风险感知准确性,但现有工具未全面满足IPDAS标准和患者需求,提示需开发新DA。
局限性
- 纳入研究存在高或不明确偏倚风险;现有DAs未全面满足IPDAS认证标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Decision aids (DAs) are evidence-based tools that support shared decision-making (SDM) implementation in practice; this study aimed to identify existing osteoporosis DAs and assess their quality and efficacy; and to gain feedback from a patient advisory group on findings and implications for further research. We searched multiple bibliographic databases to identify research studies from 2000 to 2019 and undertook an environmental scan (search conducted February 2019, repeated in March 2020). A pair of reviewers, working independently selected studies for inclusion, extracted data, evaluated each trial's risk of bias, and conducted DA quality assessment using the International Patient Decision Aid Standards (IPDAS). Public contributors (patients and caregivers with experience of osteoporosis and fragility fractures) participated in discussion groups to review a sample of DAs, express preferences for a new DA, and discuss plans for development of a new DA. We identified 6 studies, with high or unclear risk of bias. Across included studies, use of an osteoporosis DA was reported to result in reduced decisional conflict compared with baseline, increased SDM, and increased accuracy of patients' perceived fracture risk compared with controls. Eleven DAs were identified, of which none met the full set of IPDAS criteria for certification for minimization of bias. Public contributors expressed preferences for encounter DAs that are individualized to patients' own needs and risk. Using a systematic review and environmental scan, we identified 11 decision aids to inform patient decisions about osteoporosis treatment and 6 studies evaluating their effectiveness. Use of decision aids increased accuracy of risk perception and shared decision-making but the decision aids themselves fail to comprehensively meet international quality standards and patient needs, underpinning the need for new DA development.
引用
- Paskins Z, Torres Roldan VD, Hawarden AW, et al. Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan. Osteoporos Int. 2020. PMID: 32500301. doi:10.1007/s00198-020-05479-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。